Revolution Medicines Wins FDA Nod for First-Of-Its-Kind Pancreatic Cancer Drug

기사 요약

FDA approves Revolution Medicines' Rasonque for metastatic pancreatic cancer. Phase 3 trials show a 60% reduced death risk vs chemotherapy.